Quantcast

Industry news that matters to you.  Learn more

New Research Profiles the State of Biomarkers in Product Development

Industry Standard Research (ISR) today announced the release of The State of Biomarkers in Drug Development report. 44 pharmaceutical and biotechnology professionals provided their strategies, insights, and predictions in this snapshot of a rapidly evolving market. In total, 37 significant pharma and biotech companies contributed to this endeavor.

Van Andel Research Institute to Utilize Aushon BioSystems’ Microarray Technology

Aushon BioSystems, Inc., a leading provider of advanced microarray instrumentation and laboratory services for biomarker discovery, development and analysis, announced today that the Van Andel Research Institute (VARI), part of the Van Andel Institute, will utilize the Aushon 2470 Arrayer technology in its Laboratory of Cancer Immunodiagnostics to advance research efforts focusing on developing novel protein analysis methods to identify and study protein abnormalities in the blood of cancer patients. The goal of the research is to develop blood tests for the early detection or more accurate diagnosis of cancer.